Legal cannabis was one of the dominating headlines in 2018. Canada's legalization of marijuana for recreational use, legalization of recreational and medicinal marijuana in a number of U.S states, and FDA approval of the first cannabis-based medication, Epidiolex, to treat rare, severe forms of epilepsy have galvanized interests and investments in this sector.
from RTT - Biotech http://bit.ly/2IQUvCx
via IFTTT
No comments:
Post a Comment